PSA Screening for HIM Act

Hozzl · 2023-12-23T08:15:22Z

Explore the details of House Bill 1826 PSA Screening for HIM Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/23/2023, 8:15 AM

Summary of Bill HR 1826

Bill 118 HR 1826, also known as the PSA Screening for HIM Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to require the Department of Health and Human Services to conduct a public awareness campaign about the importance of prostate-specific antigen (PSA) screening for men.

The bill aims to educate men about the benefits of PSA screening in detecting prostate cancer early, which can lead to more effective treatment and improved outcomes. The campaign would also provide information about the risks and limitations of PSA screening, so that men can make informed decisions about their healthcare.

Additionally, the bill would require health insurance plans to cover the cost of PSA screening for men, ensuring that this important preventive measure is accessible to all. This provision is aimed at increasing the number of men who receive regular PSA screenings, particularly those who may not have access to or be aware of the benefits of this test. Overall, the PSA Screening for HIM Act seeks to improve public health by increasing awareness and access to PSA screening for men, ultimately leading to better outcomes for those at risk of prostate cancer.

Congressional Summary of HR 1826

Prostate-Specific Antigen Screening for High-risk Insured Men Act or the PSA Screening for HIM Act

This bill requires private health insurance plans to cover preventive prostate cancer screenings that are not already covered under the recommendations of the U.S. Preventive Services Task Force for men with a family history of prostate cancer, without imposing any cost-sharing requirement.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1826

Bill HR 1826 is currently in the status of Bill Introduced since March 28, 2023. Bill HR 1826 was introduced during Congress 118 and was introduced to the House on March 28, 2023. Bill HR 1826's most recent activity was Referred to the Subcommittee on Health. as of April 7, 2023

Bipartisan Support of Bill HR 1826

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

120

Democrat Cosponsors

100

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1826

Primary Policy Focus

Health

Potential Impact Areas

- Cancer

- Health care costs and insurance

- Health promotion and preventive care

- Medical tests and diagnostic methods

- Minority health

Alternate Title(s) of Bill HR 1826

PSA Screening for HIM Act

Prostate-Specific Antigen Screening for High-risk Insured Men Act

To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for prostate cancer screenings without the imposition of cost-sharing requirements, and for other purposes.